Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes
- 17 May 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Neurosciences
- Vol. 34 (6), 293-303
- https://doi.org/10.1016/j.tins.2011.04.001
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Angelman syndrome: advancing the research frontier of neurodevelopmental disordersJournal of Neurodevelopmental Disorders, 2010
- EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse FormationCell, 2010
- Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndromeNeurobiology of Disease, 2010
- Double‐blind therapeutic trial in Angelman syndrome using betaine and folic acidAmerican Journal of Medical Genetics Part A, 2010
- The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating ArcCell, 2010
- The non‐apoptotic role of p53 in neuronal biology: enlightening the dark side of the moonEMBO Reports, 2009
- Rapid Translation of Arc/Arg3.1 Selectively Mediates mGluR-Dependent LTD through Persistent Increases in AMPAR Endocytosis RateNeuron, 2008
- Arc/Arg3.1 Mediates Homeostatic Synaptic Scaling of AMPA ReceptorsNeuron, 2006
- Arc/Arg3.1 Interacts with the Endocytic Machinery to Regulate AMPA Receptor TraffickingNeuron, 2006
- Angelman syndrome 2005: Updated consensus for diagnostic criteriaAmerican Journal of Medical Genetics Part A, 2006